Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis

Gut Microbes. 2025 Dec;17(1):2449111. doi: 10.1080/19490976.2024.2449111. Epub 2025 Jan 8.

Abstract

Gut microbes play a crucial role in regulating the tumor microenvironment (TME) of colorectal cancer (CRC). Nevertheless, the deep mechanism between the microbiota-TME interaction has not been well explored. In this study, we for the first time discovered that Lactobacillus intestinalis (L. intestinalis) effectively suppressed tumor growth both in the AOM/DSS-induced CRC model and the ApcMin/+ spontaneous adenoma model. Our investigation revealed that L. intestinalis increased the infiltration of immune cells, particularly dendritic cells (DC), in the TME. Mechanically, the tumor-derived CCL5 induced by L. intestinalis recruited DC chemotaxis through the NOD1/NF-κB signaling pathway. In clinical samples and datasets, we found positive correlation between L. intestinalis, CCL5 level, and the DC-related genes. Our study provided a new strategy for microbial intervention for CRC and deepened the understanding of the interaction between tumor cells and the immune microenvironment modulated by gut microbes.

Keywords: CCL5; Lactobacillus intestinalis; NF-κB; colorectal cancer; dendritic cells.

MeSH terms

  • Animals
  • Carcinogenesis
  • Chemokine CCL5* / genetics
  • Chemokine CCL5* / metabolism
  • Colorectal Neoplasms* / immunology
  • Colorectal Neoplasms* / microbiology
  • Colorectal Neoplasms* / pathology
  • Dendritic Cells* / immunology
  • Gastrointestinal Microbiome*
  • Humans
  • Lactobacillus / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Nod1 Signaling Adaptor Protein / genetics
  • Nod1 Signaling Adaptor Protein / metabolism
  • Signal Transduction
  • Tumor Microenvironment* / immunology

Substances

  • Chemokine CCL5
  • NF-kappa B
  • Nod1 Signaling Adaptor Protein
  • Nod1 protein, mouse
  • Ccl5 protein, mouse

Grants and funding

This work was financially supported by the National Natural Science Foundation of China [grant no. 82203618, to L. Fan; grant no. 82273269, to L. Wang; grant no. 82303271, to Y. Zhang], Zhejiang Province Medicine and Health Science and Technology Project [grant no. 2023KY722, to L. Fan], Natural Science Foundation Joint Fund Project of Zhejiang Province [grant no. LHDMD24H160001 to S. Chen], and Beijing CSCO Clinical Oncology Research Foundation [grant no. Y-NESTLE2022ZD—0195 to M. Luo].